Atlas Trials

Pharmacokinetics, Safety, and Tolerability Study of GOPRELTO® Nasal Solution and NUMBRINO™ Nasal Solution

Clinical trial NCT04792034 · RECRUITING

Trial details

NCT number
NCT04792034
Sponsor
Noden Pharma
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
ENT DisorderNasal ProceduresNasal AnesthesiaNasal Mucosa Surgery
Start date
2025-12-06
Primary completion
2027-12-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.